Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription

The metastatic castration-resistant prostate cancer (CRPC) is a lethal form of prostate cancer, in which the expression of androgen receptor (AR) is highly heterogeneous. Indeed, lower AR expression and attenuated AR signature activity is shown in CRPC tissues, especially in the subset of neuroendoc...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncogene
Main Authors: Jia, Lin, Wu, Dinglan, Wang, Yuliang, You, Wenxing, Wang, Zhu, Xiao, Lijia, Cai, Ganhui, Xu, Zhenyu, Zou, Chang, Wang, Fei, Teoh, Jeremy Yuen-Chun, Ng, Chi-Fai, Yu, Shan, Chan, Franky L.
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group UK 2018
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6013422/
https://ncbi.nlm.nih.gov/pubmed/29555975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0198-z
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים